Slashing drug imports could trigger widespread shortages, experts said, because of America’s dependence on Chinese- and Indian-made chemical ingredients, which form the critical building blocks of ...

Feldman and Schor explain that the patent dance is a complex process to determine which of a biologic manufacturer’s patents ...

In conclusion, the 2025 CDSCO draft guidelines represent a meaningful and commendable step toward global regulatory alignment ...

The study included images of skin lesions available in the chapters related to dermatological or infectious diseases (e.g., exanthematous diseases). The images were extracted from the books and ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

Autoimmune Disease Therapeutics Market projected for significant growth from 2025 to 2035, driven by biologics, innovation, and rising prevalence Global demand for autoimmune disease therapeutics is ...

The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.

Organon's Q1 2025 earnings report showed significant declines across key financial metrics, leading to a drastic 30% drop in ...

Alvotech and its U.S. commercial partner Teva Pharmaceutical announced the launch of SELARSDI™ (ustekinumab-aekn) biosimilar ...

Prestige International Pictures, a film sales, financing and production company, will be launching at the Marché du Film during the Cannes Film Festival. The company will be headed by sales ...

The Indian government is refining biosimilar drug regulations, aligning with global standards to ensure stringent quality in research and manufacturing. These revised 'Guidelines on Similar Biologics' ...

Biocon Biologics, a subsidiary of Biocon, on Monday said that it has secured multiple market access agreements for Yesintek in the US, its biosimilar which resembles the properties of Stelara.